Bcl-G acquitted of murder!

od Tischner, D, Villunger, A
Wydane 2012

Noxa: at the tip of the balance between life and death

od Ploner, C, Kofler, R, Villunger, A
Wydane 2008

Caspase-2: killer, savior and safeguard—emerging versatile roles for an ill-defined caspase

od Krumschnabel, G, Manzl, C, Villunger, A
Wydane 2009

Guarding effector T-cell survival: all for one, Mcl-1 for all?

od Ottina, E, Pellegrini, M, Villunger, A
Wydane 2013

In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute

od Michalak, EM, Villunger, A, Adams, JM, Strasser, A
Wydane 2008

Bcl-2-regulated cell death signalling in the prevention of autoimmunity

od Tischner, D, Woess, C, Ottina, E, Villunger, A
Wydane 2010

Bim and Bmf in tissue homeostasis and malignant disease

od Piñon, JD, Labi, V, Egle, A, Villunger, A
Wydane 2008

Bim vanishes in the light of a mitotic Aurora

od Fava, L L, Haschka, M D, Villunger, A
Wydane 2013

Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?

od Labi, V, Grespi, F, Baumgartner, F, Villunger, A
Wydane w Cell Death Differ (2008)

The BH3-only protein Bad is dispensable for TNF-mediated cell death

od Ottina, E, Sochalska, M, Sgonc, R, Villunger, A
Wydane w Cell Death Dis (2015)

Correction to: The BH3-only protein Bad is dispensable for TNF-mediated cell death

od Ottina, E., Sochalska, M., Sgonc, R., Villunger, A.
Wydane w Cell Death Dis (2018)

Bid-ding for mercy: twisted killer in action

od Egle, A, Asslaber, D, Villunger, A, Pinon-Hofbauer, J
Wydane 2013

Bid-ding for mercy: twisted killer in action

od Egle, A, Asslaber, D, Villunger, A, Pinon-Hofbauer, J
Wydane 2013

Can the analysis of BH3-only protein knockout mice clarify the issue of ‘direct versus indirect' activation of Bax and Bak?

od Villunger, A, Labi, V, Bouillet, P, Adams, J, Strasser, A
Wydane 2011

The enigma of caspase-2: the laymen’s view

od Krumschnabel, G, Sohm, B, Bock, F, Manzl, C, Villunger, A
Wydane 2008

P53-induced protein with a death domain (PIDD): master of puppets?

od Bock, FJ, Peintner, L, Tanzer, M, Manzl, C, Villunger, A
Wydane w Oncogene (2012)

The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd

od Peintner, L, Dorstyn, L, Kumar, S, Aneichyk, T, Villunger, A, Manzl, C
Wydane w Cell Death Differ (2015)

Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival

od Sochalska, M, Ottina, E, Tuzlak, S, Herzog, S, Herold, M, Villunger, A
Wydane w Cell Death Differ (2016)

Mutual antagonism of TGF-beta and Interleukin-2 in cell survival and lineage commitment of induced regulatory T cells

od Tischner, D, Wiegers, G J, Fiegl, H, Drach, M, Villunger, A
Wydane 2012

MAP3K11 is a tumor suppressor targeted by the oncomiR miR-125b in early B cells

od Knackmuss, U, Lindner, S E, Aneichyk, T, Kotkamp, B, Knust, Z, Villunger, A, Herzog, S
Wydane w Cell Death Differ (2016)